160 related articles for article (PubMed ID: 28166649)
1. Evaluation of plasma antioxidant activity in rats given excess EGCg with reference to endogenous antioxidants concentrations and assay methods.
Yokotani K; Umegaki K
Free Radic Res; 2017 Feb; 51(2):193-199. PubMed ID: 28166649
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers.
Xu JZ; Yeung SY; Chang Q; Huang Y; Chen ZY
Br J Nutr; 2004 Jun; 91(6):873-81. PubMed ID: 15182391
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid.
Hatano T; Tsugawa M; Kusuda M; Taniguchi S; Yoshida T; Shiota S; Tsuchiya T
Phytochemistry; 2008 Dec; 69(18):3111-6. PubMed ID: 17889045
[TBL] [Abstract][Full Text] [Related]
4. Bioactivity of Epigallocatechin Gallate Nanoemulsions Evaluated in Mice Model.
Koutelidakis AE; Argyri K; Sevastou Z; Lamprinaki D; Panagopoulou E; Paximada E; Sali A; Papalazarou V; Mallouchos A; Evageliou V; Kostourou V; Mantala I; Kapsokefalou M
J Med Food; 2017 Sep; 20(9):923-931. PubMed ID: 28737454
[TBL] [Abstract][Full Text] [Related]
5. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans.
Kimura M; Umegaki K; Kasuya Y; Sugisawa A; Higuchi M
Eur J Clin Nutr; 2002 Dec; 56(12):1186-93. PubMed ID: 12494303
[TBL] [Abstract][Full Text] [Related]
6. Chemiluminescence analysis of the prooxidant and antioxidant effects of epigallocatechin-3-gallate.
Tian B; Sun Z; Xu Z; Hua Y
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():153-7. PubMed ID: 17392095
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of liver cancer cell proliferation and migration by a combination of (-)-epigallocatechin-3-gallate and ascorbic acid.
Wei DZ; Yang JY; Liu JW; Tong WY
J Chemother; 2003 Dec; 15(6):591-5. PubMed ID: 14998086
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.
Henning SM; Niu Y; Liu Y; Lee NH; Hara Y; Thames GD; Minutti RR; Carpenter CL; Wang H; Heber D
J Nutr Biochem; 2005 Oct; 16(10):610-6. PubMed ID: 16081270
[TBL] [Abstract][Full Text] [Related]
9. Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate.
Xie Q; Cai X; Dong X; Wang Y; Sun M; Tai L; Xu Y
Pharm Biol; 2021 Dec; 59(1):157-166. PubMed ID: 33556300
[TBL] [Abstract][Full Text] [Related]
10. Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants.
Sakagami H; Arakawa H; Maeda M; Satoh K; Kadofuku T; Fukuchi K; Gomi K
Anticancer Res; 2001; 21(4A):2633-41. PubMed ID: 11724332
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of different co-antioxidants on the photochemical- and functional-stability of epigallocatechin-3-gallate in topical creams exposed to simulated sunlight.
Scalia S; Marchetti N; Bianchi A
Molecules; 2013 Jan; 18(1):574-87. PubMed ID: 23292326
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma.
Aldini G; Yeum KJ; Carini M; Krinsky NI; Russell RM
Biochem Biophys Res Commun; 2003 Mar; 302(2):409-14. PubMed ID: 12604363
[TBL] [Abstract][Full Text] [Related]
13. Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method.
Apak R; Güçlü K; Ozyürek M; Karademir SE
J Agric Food Chem; 2004 Dec; 52(26):7970-81. PubMed ID: 15612784
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate can significantly decrease free oxygen radicals in the reperfusion injury in vivo.
Büttemeyer R; Philipp AW; Schlenzka L; Mall JW; Beissenhirtz M; Lisdat F
Transplant Proc; 2003 Dec; 35(8):3116-20. PubMed ID: 14697992
[TBL] [Abstract][Full Text] [Related]
15. Non-enzymatic antioxidant capacity (NEAC) estimated by two different dietary assessment methods and its relationship with NEAC plasma levels.
Carrión-García CJ; Guerra-Hernández EJ; García-Villanova B; Molina-Montes E
Eur J Nutr; 2017 Jun; 56(4):1561-1576. PubMed ID: 27023743
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
Ramesh E; Elanchezhian R; Sakthivel M; Jayakumar T; Senthil Kumar RS; Geraldine P; Thomas PA
Fundam Clin Pharmacol; 2008 Jun; 22(3):275-84. PubMed ID: 18485145
[TBL] [Abstract][Full Text] [Related]
17. Plasma total antioxidant capacity is associated with dietary intake and plasma level of antioxidants in postmenopausal women.
Wang Y; Yang M; Lee SG; Davis CG; Kenny A; Koo SI; Chun OK
J Nutr Biochem; 2012 Dec; 23(12):1725-31. PubMed ID: 22617460
[TBL] [Abstract][Full Text] [Related]
18. Sulfur mustard induced oxidative stress and its alteration by epigallocatechin gallate.
Pohanka M; Sobotka J; Stetina R
Toxicol Lett; 2011 Mar; 201(2):105-9. PubMed ID: 21172412
[TBL] [Abstract][Full Text] [Related]
19. ORAC and DPPH assay comparison to assess antioxidant capacity of tea infusions: relationship between total polyphenol and individual catechin content.
Roy MK; Koide M; Rao TP; Okubo T; Ogasawara Y; Juneja LR
Int J Food Sci Nutr; 2010 Mar; 61(2):109-24. PubMed ID: 20109129
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
Bannerman B; Xu L; Jones M; Tsu C; Yu J; Hales P; Monbaliu J; Fleming P; Dick L; Manfredi M; Claiborne C; Bolen J; Kupperman E; Berger A
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1145-54. PubMed ID: 21400028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
